Processing

Please wait...

PATENTSCOPE will be unavailable a few hours for maintenance reason on Tuesday 25.01.2022 at 9:00 AM CET
Settings

Settings

Goto Application

1. WO2022008438 - STABILIZED CORONA VIRUS SPIKE PROTEIN FUSION PROTEINS

Publication Number WO/2022/008438
Publication Date 13.01.2022
International Application No. PCT/EP2021/068505
International Filing Date 05.07.2021
IPC
C07K 14/005 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
005from viruses
C07K 14/165 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
005from viruses
08RNA viruses
165Coronaviridae, e.g. avian infectious bronchitis virus
A61K 39/12 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
12Viral antigens
Applicants
  • JANSSEN PHARMACEUTICALS, INC. [US]/[US]
Inventors
  • LANGEDIJK, Johannes, Petrus, Maria
  • RUTTEN, Lucy
  • JURASZEK, Jaroslaw
Agents
  • MANTEN, Annemieke
  • VERHAGE, Richard, A
  • BESLIER, Victor
  • VAN WANROOIJ, Eva
Priority Data
62/705,58406.07.2020US
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) STABILIZED CORONA VIRUS SPIKE PROTEIN FUSION PROTEINS
(FR) PROTÉINES DE SPICULE DE CORONAVIRUS STABILISÉES À TITRE DE PROTÉINES DE FUSION
Abstract
(EN) The present invention provides stabilized recombinant pre-fusion SARS CoV0-2 S proteins, nucleic acids molecules encoding the SARS CoV-2 S proteins and uses thereof.
(FR) La présente invention concerne des protéines SARS-CoV-2 S de préfusion recombinées stabilisées, des molécules d'acides nucléiques codant les protéines SARS-CoV-2 S, ainsi que leurs utilisations.
Latest bibliographic data on file with the International Bureau